Antiplatelet effect of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: An analysis of the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) Study

International Journal of Cardiology

Volumn 160, Issue 3, 2012, Pages 213-214

  Mangiacapra, Fabio ^a,b   Patti, Giuseppe ^a   Barbato, Emanuele ^b   Orlic, Dejan ^c   Peace, Aaron J ^b   D'Ambrosio, Andrea ^a   Ostojic, Miodrag ^c   Wijns, William ^b   Di Sciascio, Germano ^a  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b OLV HOSPITAL   (Belgium)

^c CLINICAL CENTER OF SERBIA   (Serbia)

Author keywords

Clopidogrel; Platelet reactivity; Primary PCI; STEMI

Indexed keywords

ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DRUG DERIVATIVE; TICLOPIDINE;

ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; HEART INFARCTION; HUMAN; INTERNATIONAL COOPERATION; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INTERNATIONALITY; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84880176319     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.06.015     Document Type: Article

References (5)

1. L. Bonello, U.S. Tantry, and R. Marcucci Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate J Am Coll Cardiol 56 2010 919 933
2. M. Frossard, I. Fuchs, and J.M. Leitner Platelet function predicts myocardial damage in patients with acute myocardial infarction Circulation 110 2004 1392 1397
3. G. Campo, M. Valgimigli, and D. Gemmati Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study J Am Coll Cardiol 48 2006 2178 2185
4. G. Patti, G. Bárczi, and D. Orlic Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study J Am Coll Cardiol 58 2011 1592 1599
5. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization Eur Heart J 31 2010 2501 2555